Stockscreener 앱 받기
0.00
100.00%
-10.62
시간 외 거래:
10.57
10.57
+
Perceptive Capital Solutions Corp 주식(PCSC)의 최신 뉴스
164,800 Shares in Perceptive Capital Solutions Corp (NASDAQ:PCSC) Bought by Toronto Dominion Bank - MarketBeat
Toronto Dominion Bank Acquires New Holdings in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Releases Quarterly Earnings Results - MarketBeat
Perceptive Capital Solutions Corp SEC 10-Q Report - TradingView
Bulldog Investors LLP Purchases New Stake in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Shaolin Capital Management LLC Has $2.55 Million Stock Position in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Shares Down 0.6%Time to Sell? - MarketBeat
Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors - The Globe and Mail
Perceptive Capital Solutions (NASDAQ:PCSC) Shares Down 0.6% – Time to Sell? - Defense World
DLD Asset Management LP Buys New Shares in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Purchases 100,000 Shares of Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Kepos Capital LP Trims Stock Position in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Decagon Asset Management LLP Acquires New Shares in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Stock Price Down 0.2%What's Next? - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Shares Up 0.3%Here's Why - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Trading Up 0.3% – Here’s What Happened - Defense World
FNY Investment Advisers LLC Has $1.02 Million Holdings in Perceptive Capital Solutions Corp (NASDAQ:PCSC) - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Stock Price Up 0.5%Here's What Happened - MarketBeat
Perceptive Capital Solutions (NASDAQ:PCSC) Trading Up 0.5% – What’s Next? - Defense World
Perceptive Capital Solutions Corp (NASDAQ:PCSC) Shares Sold by Shaolin Capital Management LLC - MarketBeat
Certain Class B Ordinary Shares of Perceptive Capital Solutions Corp are subject to a Lock-Up Agreement Ending on 8-DEC-2024. - Marketscreener.com
Perceptive Capital Solutions Corp's Lock-Up Period Will End on December 9th (NASDAQ:PCSC) - MarketBeat
Beta Bionics Closes $60M Series E Financing - FinSMEs
Introducing Perceptive: A New Name for the Global Leader in Discovery, eClinical, and Imaging Services and Solutions - PR Newswire
Private equity-backed SPAC IPOs dwindle - S&P Global
Perceptive Completes World’s First Fully Automated Dental Procedure on a Human Using AI-Driven Robotic System - Yahoo Finance
SPAC market diminished but alive despite new SEC rules - BioWorld MedTech
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its SPAC Market Update & Outlook - Business Wire
Perceptive Capital Solutions Completes $86.25M IPO - The SPAC Conference
PCSC IPO NewsPerceptive Advisors' SPAC Perceptive Capital Solutions prices $75 million IPO - renaissancecapital.com
Life Sciences Hedge Fund Perceptive Preps a New SPAC - Institutional Investor
Perceptive Capital Solutions Files for $75M IPO - DealFlow's SPAC News
Beta Bionics Secures $100 Million After FDA Approval - The Healthcare Technology Report.
Anteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalposts - Business Wire
About Us - Financial Content
Profitably Trade Stocks at 52-Week Highs - MarketBeat
VivoSense Announces Closing of $25M Series A Financing - Business Wire
StartUp Health Insights: Maverick Medical AI Closes Seed Round | Week of Mar 8, 2022 - StartUp Health
Who isn’t at a16z? - Fortune
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing - Business Wire
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III - Business Wire
Cerevel Therapeutics and Arya Sciences Acquisition Corp II Announce Business Combination, Creating a Publicly Listed Leader in Neuroscience Drug Development - Business Wire
0.15%
0.08%
자본화:
|
볼륨(24시간):